trending Market Intelligence /marketintelligence/en/news-insights/trending/T-I3wk66l5EUBz1oJpIdOw2 content esgSubNav
In This List

Bionor Pharma completes Solon Eiendom acquisition

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Bionor Pharma completes Solon Eiendom acquisition

Bionor Pharma ASA completed its acquisition of Oslo-based residential property developer Solon Eiendom AS.

The deal is part of a broader restructuring under which Bionor Pharma plans to change its name to Solon Eiendom and transfer its HIV research activities to a subsidiary.